Skip to content

Read-only version: For security reasons, the Research Information System (FIS) has been temporarily replaced by this read-only version. All public content and full texts remain available; login, editing, submission and statistics are not available. Questions: fis@uni-bamberg.de

Home › Publications › Interleukin-6 Gene Expression Changes after a 4-Week Intake of a Multispecies Probiotic in Major Depressive Disorder-Preliminary Results of the PROVIT Study

Publication

Interleukin-6 Gene Expression Changes after a 4-Week Intake of a Multispecies Probiotic in Major Depressive Disorder-Preliminary Results of the PROVIT Study

Reiter, Alexandra; Bengesser, Susanne A.; Hauschild, Anne-Christin; u. a. (2020): Interleukin-6 Gene Expression Changes after a 4-Week Intake of a Multispecies Probiotic in Major Depressive Disorder-Preliminary Results of the PROVIT Study, in: Nutrients, Basel: MDPI, Jg. 12, Nr. 9, S. 2575, doi: 10.3390/nu12092575.

Details

Faculty/Chair
Faculty/Professorship
Author
Reiter, Alexandra; Bengesser, Susanne A.; Hauschild, Anne-Christin; Birkl-Töglhofer, Anna-Maria; Fellendorf, Frederike T.; Platzer, Martina; ORCID iDFärber, Tanja; Seidl, Matthias; Mendel, Lilli-Marie; Unterweger, Renate; Lenger, Melanie; Mörkl, Sabrina; Dalkner, Nina; Birner, Armin; Queissner, Robert; Hamm, Carlo; Maget, Alexander; Pilz, Rene; Kohlhammer-Dohr, Alexandra; Wagner-Skacel, Jolana; Kreuzer, Kathrin; Schöggl, Helmut; Amberger-Otti, Daniela; Lahousen, Theresa; Leitner-Afschar, Birgitta; Haybäck, Johannes; Kapfhammer, Hans-Peter; Reininghaus, Eva
Title of the Journal
Nutrients
ISSN
2072-6643
Publisher Information
MDPI : Basel
Year of publication
2020
Volume
12
Issue
9
Language
English
DOI
Abstract

Major depressive disorder (MDD) is a prevalent disease, in which one third of sufferers do not respond to antidepressants. Probiotics have the potential to be well-tolerated and cost-effcient treatment options. However, the molecular pathways of their effects are not fully elucidated yet. Based on previous literature, we assume that probiotics can positively influence inflammatory mechanisms. We aimed at analyzing the effects of probiotics on gene expression of inflammation genes as part of the randomized, placebo-controlled, multispecies probiotics PROVIT study in Graz, Austria. Fasting blood of 61 inpatients with MDD was collected before and after four weeks of probiotic intake or placebo. We analyzed the effects on gene expression of tumor necrosis factor (TNF), nuclear factor kappa B subunit 1 (NFKB1) and interleukin-6 (IL-6). In IL-6 we found no significant main effects for group (F(1,44) = 1.33, p = ns) nor time (F(1,44) = 0.00, p = ns), but interaction was significant (F(1,44) = 5.67, p < 0.05). The intervention group showed decreasing IL-6 gene expression levels while the placebo group showed increasing gene expression levels of IL-6. Probiotics could be a useful additional treatment in MDD, due to their anti-inflammatory effects. Results of the current study are promising, but further studies are required to investigate the beneficial effects of probiotic interventions in depressed individuals.

Keywords
depression; gut-brain-axis; probiotics; gene expression; interleukin-6
Type
Article
URI
Activation date
2022-05-30

Permalink: https://fis.uni-bamberg.de/handle/uniba/54125 · Data as JSON · Cite: BibTeX · RIS

Data as of: 2026-11-16

Restricted read-only access: login, editing and submission are temporarily disabled.